These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17603169

  • 1. Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats.
    Yamabe N, Kang KS, Matsuo Y, Tanaka T, Yokozawa T.
    Biol Pharm Bull; 2007 Jul; 30(7):1289-96. PubMed ID: 17603169
    [Abstract] [Full Text] [Related]

  • 2. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
    Yamabe N, Kang KS, Goto E, Tanaka T, Yokozawa T.
    Biol Pharm Bull; 2007 Mar; 30(3):520-6. PubMed ID: 17329849
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats.
    Yokozawa T, Yamabe N, Kim HY, Kang KS, Hur JM, Park CH, Tanaka T.
    Biol Pharm Bull; 2008 Jul; 31(7):1422-8. PubMed ID: 18591786
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N, Noh JS, Park CH, Kang KS, Shibahara N, Tanaka T, Yokozawa T.
    Eur J Pharmacol; 2010 Dec 01; 648(1-3):179-87. PubMed ID: 20826139
    [Abstract] [Full Text] [Related]

  • 5. A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats.
    Yokozawa T, Yamabe N, Cho EJ, Nakagawa T, Oowada S.
    Nephron Exp Nephrol; 2004 Dec 01; 97(2):e38-48. PubMed ID: 15218322
    [Abstract] [Full Text] [Related]

  • 6. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N, Yokozawa T.
    J Pharm Pharmacol; 2006 Apr 01; 58(4):535-45. PubMed ID: 16597372
    [Abstract] [Full Text] [Related]

  • 7. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.
    Nakagawa T, Yokozawa T, Yamabe N, Rhyn DY, Goto H, Shimada Y, Shibahara N.
    J Pharm Pharmacol; 2005 Sep 01; 57(9):1205-12. PubMed ID: 16105242
    [Abstract] [Full Text] [Related]

  • 8. Antidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic rats.
    Gao D, Li Q, Gao Z, Wang L.
    Yonsei Med J; 2012 Jul 01; 53(4):691-700. PubMed ID: 22665333
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress.
    Kim HY, Yokozawa T, Cho EJ, Yamabe N.
    J Pharm Pharmacol; 2004 Oct 01; 56(10):1299-305. PubMed ID: 15482645
    [Abstract] [Full Text] [Related]

  • 10. Selective therapeutic effect of cornus officinalis fruits on the damage of different organs in STZ-induced diabetic rats.
    Han Y, Jung HW, Park YK.
    Am J Chin Med; 2014 Oct 01; 42(5):1169-82. PubMed ID: 25169907
    [Abstract] [Full Text] [Related]

  • 11. Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice.
    Park CH, Noh JS, Tanaka T, Roh SS, Lee JC, Yokozawa T.
    Arch Pharm Res; 2015 Jun 01; 38(6):1270-80. PubMed ID: 25079767
    [Abstract] [Full Text] [Related]

  • 12. The effects of corni fructus extract and its fractions against α-glucosidase inhibitory activities in vitro and sucrose tolerance in normal rats.
    Park CH, Noh JS, Tanaka T, Uebaba K, Cho EJ, Yokozawa T.
    Am J Chin Med; 2011 Jun 01; 39(2):367-80. PubMed ID: 21476212
    [Abstract] [Full Text] [Related]

  • 13. Rokumi-jio-gan-containing prescriptions regulate oxidative stress through improving dyslipidemia in a subtotal nephrectomized rat model.
    Park CH, Lee SL, Noh JS, Yokozawa T.
    J Ethnopharmacol; 2013 Jul 09; 148(2):449-58. PubMed ID: 23639360
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic parameters of morroniside in iridoid glycosides of Fructus corni processing based on back-propagation neural network.
    Cao G, Shan Q, Zhang C, Zhang Y, Cai H, Cong X, Cai B.
    Pharm Biol; 2011 Sep 09; 49(9):989-93. PubMed ID: 21591872
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats.
    Yamabe N, Yokozawa T.
    J Ethnopharmacol; 2007 Aug 15; 113(1):91-9. PubMed ID: 17606344
    [Abstract] [Full Text] [Related]

  • 16. Iridoid glycoside from Cornus officinalis ameliorated diabetes mellitus-induced testicular damage in male rats: Involvement of suppression of the AGEs/RAGE/p38 MAPK signaling pathway.
    Chen Y, Wu Y, Gan X, Liu K, Lv X, Shen H, Dai G, Xu H.
    J Ethnopharmacol; 2016 Dec 24; 194():850-860. PubMed ID: 27989876
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous Determination of 11 High-Polarity Components from Fructus Corni: A Quantitative LC-MS/MS Method for Improved Quality Control.
    Wang L, Chen H, Jiang Y, Liu Z, Wang Q, Zheng X.
    J Chromatogr Sci; 2018 Jan 01; 56(1):56-64. PubMed ID: 29036589
    [Abstract] [Full Text] [Related]

  • 18. Undescribed morroniside-like secoiridoid diglycosides with α-glucosidase inhibitory activity from Corni Fructus.
    Ye XS, He J, Xu JK, He XL, Xia CY, Yan Y, Lian WW, Zhang WK.
    Phytochemistry; 2020 Mar 01; 171():112232. PubMed ID: 31911266
    [Abstract] [Full Text] [Related]

  • 19. 7-O-galloyl-D-sedoheptulose is a novel therapeutic agent against oxidative stress and advanced glycation endproducts in the diabetic kidney.
    Yamabe N, Kang KS, Park CH, Tanaka T, Yokozawa T.
    Biol Pharm Bull; 2009 Apr 01; 32(4):657-64. PubMed ID: 19336901
    [Abstract] [Full Text] [Related]

  • 20. Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats.
    Liu HR, Tang XY, Dai DZ, Dai Y.
    J Ethnopharmacol; 2008 Aug 13; 118(3):466-72. PubMed ID: 18585879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.